CDC Study to Explore Early Development (SEED) Follow up Studies relevant to Autism Spectrum Disorder

Sponsor Deadline: 

Nov 10, 2020

Internal Deadline: 

Oct 1, 2020

Letter of Intent Deadline: 

Oct 5, 2020

Sponsor: 

Centers for Disease Control and Prevention

UI Contact: 

CDC Study to Explore Early Development (SEED) Follow up Studies relevant to Autism Spectrum Disorder
RFA-DD-21-001
Grants.gov  https://www.grants.gov/web/grants/view-opportunity.html?oppId=327720

This CDC solicitation is limited to one application per institution per component.  Please refer to this link on the UIowa Limited Submissions process   https://uiowa.infoready4.com/#competitionDetail/1759773
Only one application per institution (normally identified by having unique DUNS number) is allowed per component for this NOFO. All eligible applicants for Component A can also apply for Components B, C, D, and/or E. To be funded for components B, C, D, and/or E, eligible applicants must apply for and be funded for Component A. Separate applications are required for each component.

The purpose of this NOFO is to gain knowledge about autism spectrum disorder (ASD), including risk factors for ASD and the expression of ASD, from childhood through early adulthood, and to obtain information that can be used to improve the health and functioning of individuals with ASD as they mature. This will be completed through
1) analysis of existing data and biospecimens from preschool-aged children and their families who participated in the CDC funded study known as the Study to Explore Early Development (SEED), a multi-phase, multi-site, case-control study of children identified at age 2-5 years with ASD, other developmental disabilities (DD), and from the general population (POP); and
2) longitudinal follow-up of and research on previous SEED participants to obtain information through early adulthood on their health and functioning, service use and needs, and the impact of ASD on their families.

Component A: Enhanced Epidemiologic Research Using Existing SEED Data and Followup Surveys of Existing SEED Participants  
Component B: In-Person Assessment of Intellectual Abilities of SEED Participants
Component C: Maternal Auto-Antibody Testing
Component D: Genetic Analyses
Component E: Biorepository

Categories: 

Keywords: